GSVRX
Price
$16.01
Change
+$0.03 (+0.19%)
Updated
Aug 28 closing price
Net Assets
434.79M
RMEBX
Price
$60.89
Change
+$0.10 (+0.16%)
Updated
Aug 28 closing price
Net Assets
108.91B
Interact to see
Advertisement

GSVRX vs RMEBX

Header iconGSVRX vs RMEBX Comparison
Open Charts GSVRX vs RMEBXBanner chart's image
Goldman Sachs Large Cap Value R
Price$16.01
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets434.79M
American Funds American Mutual R2E
Price$60.89
Change+$0.10 (+0.16%)
VolumeN/A
Net Assets108.91B
GSVRX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSVRX vs. RMEBX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVRX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 109B vs. GSVRX (435M). RMEBX pays higher dividends than GSVRX: RMEBX (1.11) vs GSVRX (0.77). GSVRX was incepted earlier than RMEBX: GSVRX (18 years) vs RMEBX (11 years). GSVRX (1.50) is less costly to investors than RMEBX (1.07). GSVRX is a more actively managed with annual turnover of: 51.00 vs. RMEBX (31.00). GSVRX has a lower initial minimum investment than RMEBX: GSVRX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 6.81 vs. GSVRX (-2.85). RMEBX return over 5 years is better than : 53.09 vs. GSVRX (21.66).
GSVRXRMEBXGSVRX / RMEBX
Total Expense Ratio1.251.07117%
Annual Report Gross Expense Ratio1.501.07140%
Fund Existence18 years11 years-
Gain YTD6.17911.50954%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets435M109B0%
Annual Yield % from dividends0.771.1169%
Returns for 1 year-2.856.81-42%
Returns for 3 years11.7128.6941%
Returns for 5 years21.6653.0941%
Returns for 10 years7.4689.528%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUID4.510.09
+2.15%
authID
DNOW16.200.25
+1.57%
DNOW
ADCT3.250.03
+0.93%
ADC Therapeutics SA
EXAS46.950.24
+0.51%
Exact Sciences Corp
MSBIP23.20-0.21
-0.89%
Midland States Bancorp